
(AGENPARL) – SILVER SPRING ven 24 giugno 2022 FDA is hosting a patient workshop on May 6, 2021. This workshop will bring together patients, caregivers, advocates, and other important stakeholders to discuss ways for patients and their advocates to work with FDA to help advance regenerative medicine for rare and genetic diseases.
Fonte/Source: http://www.fda.gov/vaccines-blood-biologics/workshops-meetings-conferences-biologics/patient-engagement-regenerative-medicine-fda-cber-workshop-patient-advocates-05062021